What is the treatment for a chalazion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chalazion Treatment

Start with warm compresses (5-10 minutes, several times daily) plus eyelid hygiene as first-line therapy for all chalazia; if no improvement after several weeks, proceed to intralesional triamcinolone acetonide injection, which is nearly as effective as surgery but less painful and more convenient. 1, 2

Initial Conservative Management

  • Apply warm compresses to the affected eyelid for 5-10 minutes, multiple times daily 1
  • Follow warm compresses with gentle massage of the affected area to help express the obstructed meibomian gland 1
  • Clean eyelid margins with mild soap or commercial eyelid cleansers 1
  • Conservative treatment alone achieves resolution in only 46% of cases at 3 weeks, significantly lower than interventional approaches 2

Interventional Treatment for Persistent Chalazia

For chalazia that persist beyond several weeks of conservative therapy, intralesional triamcinolone acetonide injection (0.2 mL of 10 mg/mL) is the preferred next step, achieving 84% resolution at 3 weeks with less pain and inconvenience than surgery 2

  • Surgical incision and curettage achieves similar resolution rates (87%) but causes significantly more pain and patient inconvenience 2
  • Intense pulsed light with meibomian gland expression shows promise as a non-surgical option for recurrent multiple chalazia 1
  • Alternative experimental methods include botulinum toxin A injection, tarsal trephination, CO2 laser, or cryogenic treatment, though these lack consensus support 3

Key Clinical Distinctions

A chalazion presents as a painless nodule within the tarsal plate with gradual onset, visible meibomian gland obstruction on eyelid eversion, and association with blepharitis or meibomian gland dysfunction 4, 1

This contrasts sharply with a hordeolum (stye), which presents as a painful, erythematous nodule at the eyelid margin with rapid onset, acute inflammation, and often purulent discharge 1, 5

Critical Warning Signs Requiring Further Evaluation

Any chalazion with the following features warrants biopsy to exclude sebaceous carcinoma:

  • Recurrence in the same location, especially in elderly patients 4, 1
  • History of multiple excisions at the same site 4
  • Marked asymmetry or resistance to therapy 1, 5
  • Eyelid margin distortion, lash loss (madarosis), or ulceration 1, 5
  • Unilateral chronic blepharitis unresponsive to therapy 4, 1

Sebaceous carcinoma is rarely misdiagnosed as chalazion, leading to delayed treatment, making vigilance for atypical features essential 4

Management of Underlying Conditions

Evaluate patients with recurrent chalazia for:

  • Meibomian gland dysfunction requiring ongoing eyelid hygiene 4, 1
  • Rosacea or seborrheic dermatitis needing specific treatment 4, 1
  • Subclinical hypothyroidism, which may predispose to recurrent chalazia and respond to levothyroxine 6
  • In children, chronic blepharokeratoconjunctivitis requiring ophthalmology referral 4

Prevention Strategies

  • Maintain regular eyelid hygiene for patients with blepharitis or meibomian gland dysfunction 4, 1
  • Treat underlying skin conditions (rosacea, seborrheic dermatitis) 4, 1
  • Avoid eye makeup during active inflammation 4, 1

Natural History

Most chalazia resolve spontaneously but can persist for months 4. Cosmetic deformity of the eyelid is a potential complication 4. The condition can develop on either upper or lower eyelid and may cause localized swelling, redness, and mild discomfort 4.

References

Guideline

Chalazion and Hordeolum Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chalazion and Hordeolum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Symptoms and Features of Hordeolum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.